Rydar Equities Inc. Purchases New Position in UnitedHealth Group Incorporated $UNH

Rydar Equities Inc. bought a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 2,337 shares of the healthcare conglomerate’s stock, valued at approximately $729,000.

A number of other hedge funds have also recently modified their holdings of the business. Brighton Jones LLC grew its stake in shares of UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after buying an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC increased its holdings in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after acquiring an additional 2,324 shares in the last quarter. Forvis Mazars Wealth Advisors LLC boosted its stake in UnitedHealth Group by 2.3% in the 1st quarter. Forvis Mazars Wealth Advisors LLC now owns 3,320 shares of the healthcare conglomerate’s stock worth $1,739,000 after purchasing an additional 75 shares in the last quarter. LeConte Wealth Management LLC bought a new stake in UnitedHealth Group during the 1st quarter valued at about $338,000. Finally, George Kaiser Family Foundation lifted its position in UnitedHealth Group by 135.5% in the 1st quarter. George Kaiser Family Foundation now owns 1,100 shares of the healthcare conglomerate’s stock valued at $576,000 after acquiring an additional 633 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the stock. Jefferies Financial Group upped their target price on shares of UnitedHealth Group from $317.00 to $409.00 and gave the company a “buy” rating in a research note on Friday, October 17th. Leerink Partners set a $410.00 target price on shares of UnitedHealth Group and gave the company an “outperform” rating in a research note on Wednesday, October 29th. Royal Bank Of Canada raised their price target on UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. Truist Financial increased their target price on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a report on Tuesday, September 9th. Finally, Weiss Ratings raised shares of UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, October 24th. Seventeen equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $385.54.

UnitedHealth Group Price Performance

NYSE:UNH opened at $341.83 on Monday. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $606.36. The business’s 50-day simple moving average is $339.84 and its two-hundred day simple moving average is $317.20. The stock has a market cap of $309.65 billion, a PE ratio of 17.84, a P/E/G ratio of 2.23 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. During the same period in the prior year, the company posted $7.15 EPS. The firm’s revenue for the quarter was up 12.2% compared to the same quarter last year. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.6%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s dividend payout ratio is presently 46.14%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.